This session focuses on the evolving landscape of airway diseases, including asthma and chronic obstructive pulmonary disease (COPD). Discussions will highlight disease mechanisms, innovative therapies, precision treatment strategies, and approaches to improving long-term respiratory health outcomes.

Interstitial lung diseases represent a diverse group of complex respiratory disorders with significant clinical challenges. This session explores advances in diagnosis, disease monitoring, antifibrotic therapies, and emerging research aimed at improving patient management and quality of life.

Respiratory infections continue to be a major contributor to global morbidity and mortality. This session examines pulmonary infections, antimicrobial strategies, emerging pathogens, pandemic preparedness, and innovations in respiratory disease prevention and management.

Advances in respiratory support technologies have transformed the management of critically ill patients. This session addresses respiratory failure, mechanical ventilation strategies, extracorporeal membrane oxygenation (ECMO), and evidence-based approaches to optimizing patient outcomes in acute care settings.

This track focuses on advanced nursing care for critically ill patients with respiratory and cardiovascular compromise, including respiratory assessment, oxygen therapy, infection prevention, patient monitoring, sedation, nutrition, and multidisciplinary ICU care. It also addresses quality improvement, communication, clinical documentation, and strategies to enhance patient safety and outcomes.

Technological advancements continue to expand the capabilities of interventional pulmonology. This session highlights diagnostic and therapeutic bronchoscopy, minimally invasive procedures, airway interventions, and innovations that improve the diagnosis and treatment of respiratory diseases.

Sleep-related breathing disorders significantly impact cardiovascular, metabolic, and respiratory health. This session explores advances in sleep medicine, obstructive sleep apnea, diagnostic technologies, and therapeutic interventions that support better patient outcomes and quality of life.

Pulmonary vascular disorders require specialized diagnostic and therapeutic approaches due to their complex nature. This session examines pulmonary hypertension, vascular pathophysiology, novel treatment options, and emerging strategies for early diagnosis and disease management.

Lung cancer remains one of the most significant challenges in respiratory medicine worldwide. This session focuses on advances in thoracic oncology, molecular diagnostics, targeted therapies, early detection strategies, and personalized approaches to lung cancer management.

The integration of precision medicine and translational science is reshaping the future of pulmonary healthcare. This session explores biomarker discovery, personalized treatment approaches, disease phenotyping, and research innovations that bridge laboratory discoveries with clinical practice.

Comprehensive respiratory care extends beyond acute treatment to long-term disease management and rehabilitation. This session highlights pulmonary rehabilitation, chronic respiratory disease management, patient-centered care models, and strategies that improve functional outcomes and quality of life.

Digital transformation is creating new opportunities in respiratory healthcare delivery and clinical decision-making. This session examines artificial intelligence, predictive analytics, digital health technologies, remote monitoring, and future innovations that are shaping modern respiratory medicine.

This session explores advanced nursing approaches to airway assessment and management, mechanical ventilation, non-invasive respiratory support, ventilator monitoring, airway complications, and prevention of ventilator-associated harm. Emphasis will be placed on evidence-based practices, early recognition of deterioration, safe ventilator care, and effective strategies for weaning and liberation.